EUVADIS has been set up in Delft, The Netherlands, as an independent consultancy and advisory firm to provide institutional support to public-private partnerships for the development of new medicines for neglected diseases in order to contribute to diminishing the burden of poverty related diseases for populations in the developing world.
A perspective of enhanced control of neglected diseases in the developing world through innovative development pathways for health Technologies in combination with other interventions such as improved diagnostics and effective treatment regimes.
Strengthening public-private partnerships in health technology research and development(R&D) for neglected diseases by interlinking the different stakeholders in the value chain of health technology and ensuring sustainable connectivity.
Health technology is the application of organized knowledge and skills in the form of devices, medicines, vaccines, procedures and systems developed to solve a health problem and improve quality of life(WHO).
Through active contacts with a broad spectrum of relevant stakeholders in the health technology development field EUVADIS will function as a broker between players and networks ensuring connectivity between the links in the value chain.
By way of facilitating the coordination of an appropriate flow of crucial information and ensuring active communication between the partners EUVADIS will help to optimize momentum in the chain of health technology R&D.